News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Alper Topal: The Keynote 921 study failed for CRPC
Alper Topal/researchgate.net
Mar 18, 2025, 12:35

Alper Topal: The Keynote 921 study failed for CRPC

Alper Topal, Medical Onoclogist at Gülhane Training and Research Hospital, shared a paper Daniel P. Petrylak and colleagues authored on X:

“The Keynote 921 study failed for CRPC.

mPFS was 8.6 months in the pembro arm compared to 8.3 months in the placebo arm.mOS was 19.6 months in the pembro arm compared to 19 months in the placebo arm. Grade 3≥side effects were more common in the pembro arm.”

Pembrolizumab Plus Docetaxel Versus Docetaxel for Previously Treated Metastatic Castration-Resistant Prostate Cancer: The Randomized, Double-Blind, Phase III KEYNOTE-921 Trial

Authors: Daniel P. Petrylak et al.

Alper Topal

Alper Topal Andrew J. Armstrong Andries M. Bergman cancer Charles Schloss Christian H. Poehlein Daniel P. Petrylak Eric Levesque Ernesto Korbenfeld Gero Kramer Howard Gurney Karim Fizazi Loic Mourey Margitta Retz Maria De Santis Meital Levartovsky Nobuaki Matsubara OncoDaily Oncology Pawel Zalewski Raffaele Ratta Ray Manneh Ray McDermott Russell Pachynski Rustem Gafanov Seok Soo Byun Sergio Bracarda Tilman Todenhofer Winald Gerritsen Xin Tong Li
Special Coverage
Voices
Sep 2, 2025, 22:37
Tyler Seibert: How Much Can A GG2 Prostate Cancer Grow in 2 Months?
Societies
Sep 2, 2025, 22:03
European Liver Screening Week - European Liver Patients'​ Association
Science
Sep 2, 2025, 21:19
Mohamed Emam Sobeih: The Efficacy of Benson’s Relaxation Technique on Anorexia and Sleep in Cancer Patients
Voices
Sep 2, 2025, 20:50
Anton Gokin: Latest Updates in Oncology Market and Science
Science
Sep 2, 2025, 20:26
Yinghui Li: Novel lncRNA PLUM Drives Chemoresistance in Multiple Myeloma Through PRC2 Pathway
Societies
Sep 2, 2025, 18:53
A Busy Month of Global Healthcare Innovation and Conferences - EHFF
Voices
Sep 2, 2025, 18:26
Tong Yin Shared Details of AstraZeneca’s ECP Symposium on Breast Cancer Diagnostics
Voices
Sep 2, 2025, 17:36
Tackling Hepatitis and Its Connection to Liver Cancer - European Cancer Organisation
Blog Posts
Sep 2, 2025, 17:24
Launching the 10th LuCE Report: Marking a Decade of Evidence from Lived Experience
Career Updates
Sep 2, 2025, 17:15
Joaquim Bosch-Barrera Begins New Role as Associate Adjunct Professor at ICO
Blog Posts
Sep 2, 2025, 17:08
Aria’s Story and the Fight for Better Treatments for Childhood Cancer - Children's Cancer Institute
Science
Sep 2, 2025, 16:54
Rishabh Jain: A-BRAVE Lesson - A "Negative" Trial Shifts the Conversation